The People's Hospital of Ningxia Hui Autonomous Region
Welcome,         Profile    Billing    Logout  
 10 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xu, Xun
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

Recruiting
3
388
RoW
HLX04-Oļ¼Œrecombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis
Shanghai Henlius Biotech
Age Related Macular Degeneration
08/23
03/24
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
NCT04187443: MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

Suspended
1
45
RoW
MS-553
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd., Fountain Medical Development Co., Ltd.
Diabetic Macular Edema, Macular Edema, Type 2 Diabetes With Diabetic Macular Edema, Type 1 Diabetes With Diabetic Macular Edema, Diabetic Retinopathy
06/25
07/25
SESOP, NCT03455478: Shanghai Eye Study for Adults

Recruiting
N/A
1000000
RoW
spectacles
Shanghai Eye Disease Prevention and Treatment Center, Brien Holden Vision
Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging
11/19
11/26
CALS, NCT05770661: China Axial Length Study

Not yet recruiting
N/A
30000
RoW
Shanghai Eye Disease Prevention and Treatment Center, The Second Affiliated Hospital of Fujian Medical University, Tongji Hospital, Sichuan Provincial People's Hospital, Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, People's Hospital of Ningxia Hui Autonomous Region, He Eye Hospital, First Affiliated Hospital of Kunming Medical University, The Affiliated Hospital of Inner Mongolia Medical University, The First Affiliated Hospital of Guangxi Traditional Chinese Medical University
Axial Length, Children, China
06/23
06/25
NCT04699357: The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial

Recruiting
N/A
357
RoW
Atropine
Shanghai Eye Disease Prevention and Treatment Center
High Myopia
09/24
08/25
Zhuang, Wenjuan
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24

Download Options